× Home Simple Search Query Builder Structure Search Browse Similarity with FDA Approved Small Molecule Drugs Similarity with ChEMBL compounds Similarity with ZINC Lead-like compounds Cluster Visualization Submission Useful Resources NVIK VirtualBox Contact Us
logo
NVIK Statistics

NVI's Statistics



Table - 1: General information about NVI's

Total entriesInhibitorsTargetsIC50 [uM]Chemspider Ids
12598396096


Table - 2: Statistics of molecular properties of NVI's molecules

DescriptorsMeanMinMax
Molecular Weight401.2955.931201.84
XLogP3.35-6.1810.11
H_bond acceptors6.49128
H_boond donors2.37014
No. of rotatable bonds6.86037
Topological Polar Surface Area105.510514.53


Figure- 1: Molecular weight distribution comparison between NVI's compounds, FDA approved small molecule drugs from Drugbank,
FDA approved Nutraceutical drugs from Drugbank and Anti-TB drugs

[Top]


Figure- 2: Hydrogen bond donor distribution comparison between NVI's compounds, FDA approved small molecule drugs from Drugbank,
FDA approved Nutraceutical drugs from Drugbank and Anti-TB drugs

[Top]


Figure- 3: Hydrogen bond acceptor distribution comparison between NVI's compounds, FDA approved small molecule drugs from Drugbank,
FDA approved Nutraceutical drugs from Drugbank and Anti-TB drugs

[Top]


Figure- 4: XLogP distribution comparison between NVI's compounds, FDA approved small molecule drugs from Drugbank,
FDA approved Nutraceutical drugs from Drugbank and Anti-TB drugs

[Top]


Figure- 5: Number of rotatable bonds distribution comparison between NVI's compounds, FDA approved small molecule drugs from Drugbank,
FDA approved Nutraceutical drugs from Drugbank and Anti-TB drugs

[Top]


Figure- 6:Topological Polar surface area distribution comparison between NVI's compounds, FDA approved small molecule drugs from Drugbank,
FDA approved Nutraceutical drugs from Drugbank and Anti-TB drugs

[Top]